KEYSTONE
Live / Registered — Registered (as of 16 May 2023)
What this means for you
Registered since 16 May 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 May 2029: the §8 declaration of use).
Record
- Serial number
- 97028343
- Registration number
- 7056750
- Mark type
- Design + words
- Filed
- 15 Sept 2021
- Published for opposition
- 02 Aug 2022
- Registered
- 16 May 2023
- Next maintenance filing
- §8 declaration of use, due by 16 May 2029 (grace period to 16 Nov 2029)
- Attorney of record
- Susan A. Smith
Goods and services
- Class 042 — Scientific and technological services: providing medical research information in the field of clinical trials in relation to hemophilia and gene therapy; medical research in the field of hemophilia and gene therapy
Owner
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 16 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Mar 2023 — USE AMENDMENT FILED
- 14 Mar 2023 — SOU EXTENSION 1 GRANTED
- 01 Mar 2023 — SOU EXTENSION 1 FILED
- 14 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 01 Mar 2023 — TEAS STATEMENT OF USE RECEIVED
- 27 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Aug 2022 — PUBLISHED FOR OPPOSITION